Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 197

1.

Prophylactic antiepileptic treatment with levetiracetam for patients undergoing supratentorial brain tumor surgery: a two-center matched cohort study.

Kamenova M, Stein M, Ram Z, Grossman R, Guzman R, Mariani L, Roth J, Soleman J.

Neurosurg Rev. 2019 May 16. doi: 10.1007/s10143-019-01111-6. [Epub ahead of print]

PMID:
31098789
2.

Mutational patterns and regulatory networks in epigenetic subgroups of meningioma.

Paramasivam N, Hübschmann D, Toprak UH, Ishaque N, Neidert M, Schrimpf D, Stichel D, Reuss D, Sievers P, Reinhardt A, Wefers AK, Jones DTW, Gu Z, Werner J, Uhrig S, Wirsching HG, Schick M, Bewerunge-Hudler M, Beck K, Brehmer S, Urbschat S, Seiz-Rosenhagen M, Hänggi D, Herold-Mende C, Ketter R, Eils R, Ram Z, Pfister SM, Wick W, Weller M, Grossmann R, von Deimling A, Schlesner M, Sahm F.

Acta Neuropathol. 2019 May 8. doi: 10.1007/s00401-019-02008-w. [Epub ahead of print]

PMID:
31069492
3.

Comparison of Motor Outcome in Patients Undergoing Awake vs General Anesthesia Surgery for Brain Tumors Located Within or Adjacent to the Motor Pathways.

Zelitzki R, Korn A, Arial E, Ben-Harosh C, Ram Z, Grossman R.

Neurosurgery. 2019 Feb 20. pii: nyz007. doi: 10.1093/neuros/nyz007. [Epub ahead of print]

PMID:
30783667
4.

The Impact of Colloid Cyst Treatment on Neurocognition.

Roth J, Sela G, Andelman F, Nossek E, Elran H, Ram Z.

World Neurosurg. 2019 Jan 29. pii: S1878-8750(19)30177-9. doi: 10.1016/j.wneu.2019.01.079. [Epub ahead of print]

PMID:
30703590
5.

Plurihormonal Pituitary Tumor of Pit-1 and SF-1 Lineages, with Synchronous Collision Corticotroph Tumor: a Possible Stem Cell Phenomenon.

Tordjman KM, Greenman Y, Ram Z, Hershkovitz D, Aizenstein O, Ariel O, Asa SL.

Endocr Pathol. 2019 Mar;30(1):74-80. doi: 10.1007/s12022-018-9562-3.

PMID:
30610567
6.

Acute subdural hematomas in shunted normal-pressure hydrocephalus patients - Management options and literature review: A case-based series.

Berger A, Constantini S, Ram Z, Roth J.

Surg Neurol Int. 2018 Nov 28;9:238. doi: 10.4103/sni.sni_338_18. eCollection 2018.

7.

Increased compliance with tumor treating fields therapy is prognostic for improved survival in the treatment of glioblastoma: a subgroup analysis of the EF-14 phase III trial.

Toms SA, Kim CY, Nicholas G, Ram Z.

J Neurooncol. 2019 Jan;141(2):467-473. doi: 10.1007/s11060-018-03057-z. Epub 2018 Dec 1.

8.

An integrated genomic analysis of anaplastic meningioma identifies prognostic molecular signatures.

Collord G, Tarpey P, Kurbatova N, Martincorena I, Moran S, Castro M, Nagy T, Bignell G, Maura F, Young MD, Berna J, Tubio JMC, McMurran CE, Young AMH, Sanders M, Noorani I, Price SJ, Watts C, Leipnitz E, Kirsch M, Schackert G, Pearson D, Devadass A, Ram Z, Collins VP, Allinson K, Jenkinson MD, Zakaria R, Syed K, Hanemann CO, Dunn J, McDermott MW, Kirollos RW, Vassiliou GS, Esteller M, Behjati S, Brazma A, Santarius T, McDermott U.

Sci Rep. 2018 Sep 10;8(1):13537. doi: 10.1038/s41598-018-31659-0.

9.

Image-guided surgery using near-infrared Turn-ON fluorescent nanoprobes for precise detection of tumor margins.

Blau R, Epshtein Y, Pisarevsky E, Tiram G, Israeli Dangoor S, Yeini E, Krivitsky A, Eldar-Boock A, Ben-Shushan D, Gibori H, Scomparin A, Green O, Ben-Nun Y, Merquiol E, Doron H, Blum G, Erez N, Grossman R, Ram Z, Shabat D, Satchi-Fainaro R.

Theranostics. 2018 May 24;8(13):3437-3460. doi: 10.7150/thno.23853. eCollection 2018.

10.

Reverting the molecular fingerprint of tumor dormancy as a therapeutic strategy for glioblastoma.

Tiram G, Ferber S, Ofek P, Eldar-Boock A, Ben-Shushan D, Yeini E, Krivitsky A, Blatt R, Almog N, Henkin J, Amsalem O, Yavin E, Cohen G, Lazarovici P, Lee JS, Ruppin E, Milyavsky M, Grossman R, Ram Z, Calderón M, Haag R, Satchi-Fainaro R.

FASEB J. 2018 Jun 1:fj201701568R. doi: 10.1096/fj.201701568R. [Epub ahead of print]

PMID:
29856660
11.

Quality of Life in Patients With Glioblastoma Treated With Tumor-Treating Fields-Reply.

Stupp R, Ram Z.

JAMA. 2018 May 1;319(17):1823. doi: 10.1001/jama.2018.1862. No abstract available.

PMID:
29715353
12.

Improvement in cognitive function after surgery for low-grade glioma.

Barzilai O, Ben Moshe S, Sitt R, Sela G, Shofty B, Ram Z.

J Neurosurg. 2018 Mar 1:1-9. doi: 10.3171/2017.9.JNS17658. [Epub ahead of print]

PMID:
29570009
13.

Nasoseptal Flap for Skull Base Reconstruction in Children.

Ben-Ari O, Wengier A, Ringel B, Carmel Neiderman NN, Ram Z, Margalit N, Fliss DM, Abergel A.

J Neurol Surg B Skull Base. 2018 Feb;79(1):37-41. doi: 10.1055/s-0037-1617435. Epub 2018 Jan 11. Review.

14.

Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma: A Secondary Analysis of a Randomized Clinical Trial.

Taphoorn MJB, Dirven L, Kanner AA, Lavy-Shahaf G, Weinberg U, Taillibert S, Toms SA, Honnorat J, Chen TC, Sroubek J, David C, Idbaih A, Easaw JC, Kim CY, Bruna J, Hottinger AF, Kew Y, Roth P, Desai R, Villano JL, Kirson ED, Ram Z, Stupp R.

JAMA Oncol. 2018 Apr 1;4(4):495-504. doi: 10.1001/jamaoncol.2017.5082.

15.

MRI radiomics analysis of molecular alterations in low-grade gliomas.

Shofty B, Artzi M, Ben Bashat D, Liberman G, Haim O, Kashanian A, Bokstein F, Blumenthal DT, Ram Z, Shahar T.

Int J Comput Assist Radiol Surg. 2018 Apr;13(4):563-571. doi: 10.1007/s11548-017-1691-5. Epub 2017 Dec 21.

PMID:
29270916
16.

Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial.

Stupp R, Taillibert S, Kanner A, Read W, Steinberg D, Lhermitte B, Toms S, Idbaih A, Ahluwalia MS, Fink K, Di Meco F, Lieberman F, Zhu JJ, Stragliotto G, Tran D, Brem S, Hottinger A, Kirson ED, Lavy-Shahaf G, Weinberg U, Kim CY, Paek SH, Nicholas G, Bruna J, Hirte H, Weller M, Palti Y, Hegi ME, Ram Z.

JAMA. 2017 Dec 19;318(23):2306-2316. doi: 10.1001/jama.2017.18718. Erratum in: JAMA. 2018 May 1;319(17):1824.

17.

Surgery for Recurrent High-Grade Glioma After Treatment with Bevacizumab.

Blumenthal DT, Kanner AA, Aizenstein O, Cagnano E, Greenberg A, Hershkovitz D, Ram Z, Bokstein F.

World Neurosurg. 2018 Feb;110:e727-e737. doi: 10.1016/j.wneu.2017.11.105. Epub 2017 Nov 26.

PMID:
29183864
18.

Co-targeting the tumor endothelium and P-selectin-expressing glioblastoma cells leads to a remarkable therapeutic outcome.

Ferber S, Tiram G, Sousa-Herves A, Eldar-Boock A, Krivitsky A, Scomparin A, Yeini E, Ofek P, Ben-Shushan D, Vossen LI, Licha K, Grossman R, Ram Z, Henkin J, Ruppin E, Auslander N, Haag R, Calderón M, Satchi-Fainaro R.

Elife. 2017 Oct 4;6. pii: e25281. doi: 10.7554/eLife.25281.

19.

Elaborate mapping of the posterior visual pathway in awake craniotomy.

Shahar T, Korn A, Barkay G, Biron T, Hadanny A, Gazit T, Nossek E, Ekstein M, Kesler A, Ram Z.

J Neurosurg. 2018 May;128(5):1503-1511. doi: 10.3171/2017.2.JNS162757. Epub 2017 Aug 25.

PMID:
28841121
20.

Malignant transformation of a conservatively managed incidental childhood cerebral mass lesion: controversy regarding management paradigm.

Soleman J, Roth J, Ram Z, Yalon M, Constantini S.

Childs Nerv Syst. 2017 Dec;33(12):2169-2175. doi: 10.1007/s00381-017-3566-z. Epub 2017 Aug 14.

PMID:
28808787
21.

Intra-operative multi-site stimulation: Expanding methodology for cortical brain mapping of language functions.

Gonen T, Gazit T, Korn A, Kirschner A, Perry D, Hendler T, Ram Z.

PLoS One. 2017 Jul 10;12(7):e0180740. doi: 10.1371/journal.pone.0180740. eCollection 2017.

22.

Meningiomas induced by low-dose radiation carry structural variants of NF2 and a distinct mutational signature.

Sahm F, Toprak UH, Hübschmann D, Kleinheinz K, Buchhalter I, Sill M, Stichel D, Schick M, Bewerunge-Hudler M, Schrimpf D, Zadeh G, Aldape K, Herold-Mende C, Beck K, Staszewski O, Prinz M, Harosh CB, Eils R, Sturm D, Jones DTW, Pfister SM, Paulus W, Ram Z, Schlesner M, Grossman R, von Deimling A.

Acta Neuropathol. 2017 Jul;134(1):155-158. doi: 10.1007/s00401-017-1715-9. Epub 2017 May 4. No abstract available.

PMID:
28474103
23.

Augmented expression of RUNX1 deregulates the global gene expression of U87 glioblastoma multiforme cells and inhibits tumor growth in mice.

Bogoch Y, Friedlander-Malik G, Lupu L, Bondar E, Zohar N, Langier S, Ram Z, Nachmany I, Klausner JM, Pencovich N.

Tumour Biol. 2017 Apr;39(4):1010428317698357. doi: 10.1177/1010428317698357.

PMID:
28443460
24.

Tumor-treating fields plus chemotherapy versus chemotherapy alone for glioblastoma at first recurrence: a post hoc analysis of the EF-14 trial.

Kesari S, Ram Z; EF-14 Trial Investigators.

CNS Oncol. 2017 Jul;6(3):185-193. doi: 10.2217/cns-2016-0049. Epub 2017 Apr 12.

25.

Proceedings of the WFNS Neuro-Oncology Committee Workshop Rome 2015.

Au K, Ram Z, Zadeh G, Aldape K, Balogun J, Barani I, DiMeco F, Goel A, Khu K, Lang FF, Lund-Johansen M, Maldaun M, Tabatabai G, Tonn JC, Westphal M.

Surg Neurol Int. 2016 Dec 12;7(Suppl 40):S963-S975. doi: 10.4103/2152-7806.195563. eCollection 2016. No abstract available.

26.

Regression of intracranial meningioma following treatment with nivolumab: Case report and review of the literature.

Gelerstein E, Berger A, Jonas-Kimchi T, Strauss I, Kanner AA, Blumenthal DT, Gottfried M, Margalit N, Ram Z, Shahar T.

J Clin Neurosci. 2017 Mar;37:51-53. doi: 10.1016/j.jocn.2016.11.011. Epub 2017 Jan 12. Review.

PMID:
28089420
27.

Surgery-Independent Language Function Decline in Patients Undergoing Awake Craniotomy.

Gonen T, Sela G, Yanakee R, Ram Z, Grossman R.

World Neurosurg. 2017 Mar;99:674-679. doi: 10.1016/j.wneu.2016.12.081. Epub 2016 Dec 27.

PMID:
28034812
28.

Surgical Resection of Cerebral Metastases Leads to Faster Resolution of Peritumoral Edema than Stereotactic Radiosurgery: A Volumetric Analysis.

Shimony N, Shofty B, Harosh CB, Sitt R, Ram Z, Grossman R.

Ann Surg Oncol. 2017 May;24(5):1392-1398. doi: 10.1245/s10434-016-5709-y. Epub 2016 Nov 28.

PMID:
27896517
29.

Perioperative Risk Assessment of Patients with Gliomatosis Cerebri.

Shimony N, Shofty B, Ram Z, Grossman R.

World Neurosurg. 2017 Feb;98:334-338. doi: 10.1016/j.wneu.2016.11.014. Epub 2016 Nov 9.

PMID:
27836704
30.

Dynamics of FLAIR Volume Changes in Glioblastoma and Prediction of Survival.

Grossman R, Shimony N, Shir D, Gonen T, Sitt R, Kimchi TJ, Harosh CB, Ram Z.

Ann Surg Oncol. 2017 Mar;24(3):794-800. doi: 10.1245/s10434-016-5635-z. Epub 2016 Oct 20.

PMID:
27766560
31.

Clinical utility and treatment outcome of comprehensive genomic profiling in high grade glioma patients.

Blumenthal DT, Dvir A, Lossos A, Tzuk-Shina T, Lior T, Limon D, Yust-Katz S, Lokiec A, Ram Z, Ross JS, Ali SM, Yair R, Soussan-Gutman L, Bokstein F.

J Neurooncol. 2016 Oct;130(1):211-219. Epub 2016 Aug 16.

PMID:
27531351
32.

Expression level of miRNAs on chromosome 14q32.31 region correlates with tumor aggressiveness and survival of glioblastoma patients.

Shahar T, Granit A, Zrihan D, Canello T, Charbit H, Einstein O, Rozovski U, Elgavish S, Ram Z, Siegal T, Lavon I.

J Neurooncol. 2016 Dec;130(3):413-422. Epub 2016 Aug 29.

PMID:
27573219
33.

Restoring the oncosuppressor activity of microRNA-34a in glioblastoma using a polyglycerol-based polyplex.

Ofek P, Calderón M, Mehrabadi FS, Krivitsky A, Ferber S, Tiram G, Yerushalmi N, Kredo-Russo S, Grossman R, Ram Z, Haag R, Satchi-Fainaro R.

Nanomedicine. 2016 Oct;12(7):2201-2214. doi: 10.1016/j.nano.2016.05.016. Epub 2016 Jun 1.

34.

A non-aggressive, highly efficient, enzymatic method for dissociation of human brain-tumors and brain-tissues to viable single-cells.

Volovitz I, Shapira N, Ezer H, Gafni A, Lustgarten M, Alter T, Ben-Horin I, Barzilai O, Shahar T, Kanner A, Fried I, Veshchev I, Grossman R, Ram Z.

BMC Neurosci. 2016 Jun 1;17(1):30. doi: 10.1186/s12868-016-0262-y.

35.

Treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists.

Greenman Y, Cooper O, Yaish I, Robenshtok E, Sagiv N, Jonas-Kimchi T, Yuan X, Gertych A, Shimon I, Ram Z, Melmed S, Stern N.

Eur J Endocrinol. 2016 Jul;175(1):63-72. doi: 10.1530/EJE-16-0206. Epub 2016 May 5.

PMID:
27150495
36.

Dendritic Cells in the Context of Human Tumors: Biology and Experimental Tools.

Volovitz I, Melzer S, Amar S, Bocsi J, Bloch M, Efroni S, Ram Z, Tárnok A.

Int Rev Immunol. 2016;35(2):116-35. doi: 10.3109/08830185.2015.1096935. Review.

PMID:
27007190
37.

Perioperative pregabalin for reducing pain, analgesic consumption, and anxiety and enhancing sleep quality in elective neurosurgical patients: a prospective, randomized, double-blind, and controlled clinical study.

Shimony N, Amit U, Minz B, Grossman R, Dany MA, Gonen L, Kandov K, Ram Z, Weinbroum AA.

J Neurosurg. 2016 Dec;125(6):1513-1522. Epub 2016 Feb 12.

PMID:
26871201
38.

Craniectomy Versus Craniotomy for Posterior Fossa Metastases: Complication Profile.

Hadanny A, Rozovski U, Nossek E, Shapira Y, Strauss I, Kanner AA, Sitt R, Ram Z, Shahar T.

World Neurosurg. 2016 May;89:193-8. doi: 10.1016/j.wneu.2016.01.076. Epub 2016 Feb 4.

PMID:
26852713
39.

Impact of Resecting Radiation Necrosis and Pseudoprogression on Survival of Patients with Glioblastoma.

Grossman R, Shimony N, Hadelsberg U, Soffer D, Sitt R, Strauss N, Corn BW, Ram Z.

World Neurosurg. 2016 May;89:37-41. doi: 10.1016/j.wneu.2016.01.020. Epub 2016 Jan 22.

PMID:
26805684
40.

Posterior Fossa Intra-Axial Tumors in Adults.

Grossman R, Ram Z.

World Neurosurg. 2016 Apr;88:140-5. doi: 10.1016/j.wneu.2015.12.066. Epub 2015 Dec 29. Review.

PMID:
26743385
41.

Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial.

Stupp R, Taillibert S, Kanner AA, Kesari S, Steinberg DM, Toms SA, Taylor LP, Lieberman F, Silvani A, Fink KL, Barnett GH, Zhu JJ, Henson JW, Engelhard HH, Chen TC, Tran DD, Sroubek J, Tran ND, Hottinger AF, Landolfi J, Desai R, Caroli M, Kew Y, Honnorat J, Idbaih A, Kirson ED, Weinberg U, Palti Y, Hegi ME, Ram Z.

JAMA. 2015 Dec 15;314(23):2535-43. doi: 10.1001/jama.2015.16669.

42.

Stereotactic radiosurgery (SRS) in high-grade glioma: judicious selection of small target volumes improves results.

Bokstein F, Blumenthal DT, Corn BW, Gez E, Matceyevsky D, Shtraus N, Ram Z, Kanner AA.

J Neurooncol. 2016 Feb;126(3):551-7. doi: 10.1007/s11060-015-1997-5. Epub 2015 Nov 24.

PMID:
26603164
43.

China's Medical Education and INR Training.

Nossek E, Ram Z.

World Neurosurg. 2016 Feb;86:49-51. doi: 10.1016/j.wneu.2015.09.084. Epub 2015 Dec 19. No abstract available.

PMID:
26433099
44.

Patterns of Failure after Stereotactic Radiosurgery of the Resection Cavity Following Surgical Removal of Brain Metastases.

Strauss I, Corn BW, Krishna V, Shahar T, Matceyevsky D, Gez E, Shtraus N, Ram Z, Kanner AA.

World Neurosurg. 2015 Dec;84(6):1825-31. doi: 10.1016/j.wneu.2015.07.073. Epub 2015 Aug 14.

PMID:
26283490
45.

Improving Vascular Neurosurgical Skills in an Era of Diminished Microsurgical Exposure.

Nossek E, Ram Z.

World Neurosurg. 2015 Oct;84(4):878-80. doi: 10.1016/j.wneu.2015.06.028. Epub 2015 Jun 25. No abstract available.

PMID:
26118719
46.

Calcification in high grade gliomas treated with bevacizumab.

Blumenthal DT, Aisenstein O, Ben-Horin I, Ben Bashat D, Artzi M, Corn BW, Kanner AA, Ram Z, Bokstein F.

J Neurooncol. 2015 Jun;123(2):283-8. doi: 10.1007/s11060-015-1796-z. Epub 2015 May 5.

PMID:
25939440
47.

Endoscopic considerations treating hydrocephalus caused by basal ganglia and large thalamic tumors.

Roth J, Ram Z, Constantini S.

Surg Neurol Int. 2015 Apr 2;6:56. doi: 10.4103/2152-7806.154467. eCollection 2015.

48.

Response.

Shahar T, Rozovski U, Ram Z.

J Neurosurg. 2015 Feb;122(2):275. No abstract available.

PMID:
25763428
49.

Conflicting pathology reports: a diagnostic dilemma.

Shahar T, Rozovski U, Shapira Y, Nossek E, Zelikovich B, Jossiphov J, Ram Z, Kanner AA, Siegal T, Blumenthal DT, Lavon I.

J Neurosurg. 2015 Feb;122(2):276-9. doi: 10.3171/2014.10.JNS131518. Epub 2014 Nov 28.

PMID:
25423268
50.

Post Hoc analyses of intention-to-treat population in phase III comparison of NovoTTF-100A™ system versus best physician's choice chemotherapy.

Kanner AA, Wong ET, Villano JL, Ram Z; EF-11 Investigators.

Semin Oncol. 2014 Oct;41 Suppl 6:S25-34. doi: 10.1053/j.seminoncol.2014.09.008. Epub 2014 Sep 16. Erratum in: Semin Oncol. 2015 Jun;42(3):e56-66.

Supplemental Content

Support Center